News | May 29, 2014

Accuray Announces 500th TomoTherapy System Installation

Milestone system to handle full patient load for new, integrated cancer center in Scottsdale, Ariz.

Accuray 500th TomoTherapy System Installation TomoHDA Arizona

May 29, 2014 — Accuray Inc. announced the installation of its 500th TomoTherapy system at the grand opening of Palo Verde Cancer Center – Scottsdale in Scottsdale, Ariz. The system, a TomoHDA model, is the only radiation therapy device at the new center, which also offers medical oncology services. The center’s decision to invest in the latest TomoTherapy offering reflects growing confidence industry-wide in the enhanced performance and clinical versatility of the technology, long known for its superior radiation therapy delivery, precision and treatment quality.

The TomoHDA System offers fast, reliable, accurate and flexible treatment planning and delivery for each patient, regardless of the location, size and complexity of the tumor. It is an ideal option for treating a wide range of cancers, including recurrent disease in patients who have already received maximum radiation doses to critical organs.

“We analyzed all radiation therapy offerings when planning our new, fully-integrated cancer center, and chose the TomoHDA system for its outstanding speed, performance and simplicity,” said Lauren Stegman, medical director of radiation oncology at Palo Verde Cancer Center – Scottsdale. “We wanted technology that would allow us to treat the broadest range of patients, and we find TomoHDA treatment planning to be flexible and easy-to-use. After working with older TomoTherapy equipment for nearly a decade and with the Accuray CyberKnife System at our affiliate site, the Phoenix CyberKnife and Radiation Oncology Center, we are confident that this next generation TomoHDA technology will allow us to treat more patients effectively. The System is the perfect complement to our existing treatment offerings and will further ensure we won’t have to turn away any difficult-to-treat patients.”

For more information: www.accuray.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...